Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Brain Injury|January 18, 2021
Original experimental rat model of blast-induced mild traumatic brain injury: a pilot studyHiroshi Matsuura, Mitsuo Ohnishi, Yoshichika Yoshioka, et al.
Virology Journal|August 19, 2024
Bacterial sepsis causes more dramatic pathogenetic changes in the Th1 pathway than does viral (COVID-19) sepsis: a prospective observational study of whole blood transcriptomesArisa Muratsu, Sayaka Oda, Shinya Onishi, et al.
Frontiers in Immunology|April 4, 2024
T cell dysfunction in elderly ARDS patients based on miRNA and mRNA integration analysisYumi Mitsuyama, Hisatake Matsumoto, Yuki Togami, et al.
Journal of Clinical Immunology|November 4, 2022
Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 PatientsTakeshi Ebihara, Tsunehiro Matsubara, Yuki Togami, et al.
Acute Medicine & Surgery|April 3, 2025
mRNA-miRNA integration analysis of T-cell exhaustion in sepsis from community-acquired pneumoniaSayaka Oda, Hisatake Matsumoto, Yuki Togami, et al.
Frontiers in Immunology|January 31, 2022
Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With SepsisTakeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, et al.
Molecular Therapy. Nucleic Acids|July 20, 2022
Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patientsYuki Togami, Hisatake Matsumoto, Jumpei Yoshimura, et al.
Frontiers in Immunology|July 5, 2022
Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, et al.
Critical Care (London, England)|August 6, 2022
Development of clinical phenotypes and biological profiles via proteomic analysis of trauma patientsJotaro Tachino, Hisatake Matsumoto, Fuminori Sugihara, et al.
Nature Communications|August 9, 2024
Atypical and non-classical CD45RB<sup>lo</sup> memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19David G Priest, Takeshi Ebihara, Janyerkye Tulyeu, et al.
Pageof 3